Analyst Opinion On How To Bet On Ensco plc (ESV), BioTime, Inc. (BTX)

Ensco plc (NYSE:ESV) recently saw its volume around 19.75 million shares and on average it trades 14.43 million shares a day. The opening price of $6.26, led it to gain 7.13% to reach $6.61 upon the closing bell.

Ensco plc (ESV) Analyst Opinion

Ensco plc has a consensus hold rating from 32 Wall Street analysts, and the number of shares currently sold short amount to at least 16.43% of shares outstanding. The stock spiked 13.57% last month and is up 11.84 this year. Wall Street is only getting more bullish on the stock, with 16 of analysts who cover ESV having a buy-equivalent rating. Analysts have placed a $6.59 price target on Ensco plc, suggesting a -0.3% decline from recent close. It’s currently trading about -45.1% below its 52-week high.

Ensco plc Earnings Surprise

Ensco plc (ESV) surprised the stock market in its last reported earnings when it earned -$0.05 a piece versus the consensus-estimated -$0.13. Its revenue totaled $458.61 million up 0.24% from the previous quarter.

Ensco plc (NYSE:ESV) Intraday View

This stock (ESV) is ahead of its 52-week low with 61.22%. Its last month’s stock price volatility remained 5.2% which for the week stands at 4.29%. The share price has moved forward from its 20 days moving average, trading at a distance of 17.48% and stays 19.47% away from its 50 days moving average. Over the last five days, shares have managed 12.8% gains and now is up 9.48% since hitting its 200-day moving average of $5.28. Ensco plc (ESV) has made its way to a 12-month decline of -35.26%.

Turning to BioTime, Inc. (NYSE:BTX), its shares were trading at $2.38 a gain of $0.09, on the trading floor. The stock, after opening at $2.33, touched a high of $2.43 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.7. BioTime, Inc. has 1 buy ratings, 0 holds and 0 sells even after the stock tumbled -37.37% from its high of $3.80 to a $315.92 million market value through last close.

BioTime, Inc. (BTX) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 1.67 to 1.67 during a month. Analysts set a 12-month price target of $6.17 a share. The target implies a 159.24% spike from where the shares are currently trading. Also, the current price highlights a discount of 173.11% to analysts’ high consensus price target.

BioTime, Inc. (NYSE:BTX) Intraday Trading

The counter witnessed a trading volume of 0.44 million shares versus an average volume of 0.41 million shares during last trading session. Its last month’s stock price volatility remained 5.77% which for the week approaches 4.67%. The lowest price the stock reached in the last trading day was $2.32 and compares with the $2.10 52-week low. The stock recovered 13.33% since its low point and has performed 10.7% year-to-date.

SHARE
Previous articleWall Street Analyst Actions To Watch: Intec Pharma Ltd. (NTEC), MagnaChip Semiconductor Corporation (MX)
Next articleAnalysts Swing to Diverse Views for Recon Technology, Ltd. (RCON), Oceaneering International, Inc. (OII)